Cargando...
Global clinical response in Cushing’s syndrome patients treated with mifepristone
OBJECTIVE: Mifepristone, a glucocorticoid receptor antagonist, improves clinical status in patients with Cushing’s syndrome (CS). We examined the pattern, reliability and correlates of global clinical response (GCR) assessments during a 6-month clinical trial of mifepristone in CS. DESIGN: Post hoc...
Gardado en:
| Publicado en: | Clin Endocrinol (Oxf) |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BlackWell Publishing Ltd
2014
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4255292/ https://ncbi.nlm.nih.gov/pubmed/24102404 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cen.12332 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|